mHealth Screening to Prevent Strokes "mSToPS"

Active, not recruiting

Phase N/A Results N/A

Update History

23 Jun '17
Trial was updated to "N/A."
The gender criteria for eligibility was updated to "All."
3 Dec '15
A location was updated in La Jolla.
New
The overall status was removed for Scripps Translational Science Institute.
21 Nov '15
The Summary of Purpose was updated.
New
The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data, and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previously undiagnosed atrial fibrillation, and provide clinical evidence of an outcomes benefit associated with this early detection.
Old
The purpose of this study is to investigate whether it is possible to identify a high-risk cohort suitable for screening for asymptomatic atrial fibrillation using claims data,and then engage those individuals in a mobile health technology-enabled home monitoring program in order to document previously undiagnosed atrial fibrillation, and provide clinical evidence of an outcomes benefit associated with this early detection.
The description was updated.
New
The purpose of this study is to propose to study two different methods of intermittent rhythm monitoring in a cohort of individuals without prior history of atrial fibrillation, but determined to be at increased risk based on clinical risk factors, and compare the rate of atrial fibrillation detection through monitoring relative to routine care.
Old
The purpose of this study is to propose to study two different methods of intermittent rhythm monitoring in a cohort of individuals without prior history of atrial fibrillation but determined to be at increased risk based on clinical risk factors, and compare the rate of atrial fibrillation detection through monitoring relative to routine care.
The eligibility criteria were updated.
New
Participants: The study population will be derived from the Aetna and Medicare populations. Inclusion Criteria: - Male or females age > 75 or - Male age > 55, or females age > 65, and - Prior CVA, or - Heart failure, or - Diagnosis of both diabetes and hypertension, or - Mitral valve disease, or - Left ventricular hypertrophy, or - COPD requiring home O2, or - Sleep apnea, or - History of pulmonary embolism, or - History of myocardial infarction, or - Diagnosis of obesity Exclusion Criteria: - Current or prior diagnosis of atrial fibrillation, atrial flutter or atrial tachycardia - Receiving chronic anticoagulation therapy - Hospice care - End stage renal disease - Diagnosis of moderate or greater dementia - Implantable pacemaker and/or defibrillator - History of skin allergies to adhesive patches - Known metastatic cancer - Aetna Compassionate Care Program (ACCP) participants - individuals with advanced illness and limited life expectancy
Old
Inclusion Criteria: - Male age > 55, or females age > 65, and - Prior CVA, or - Heart failure, or - Diagnosis of both diabetes and hypertension, or - Mitral valve disease, or - Left ventricular hypertrophy, or - COPD requiring home O2, or - Sleep apnea, or - History of pulmonary embolism, or - History of myocardial infarction, or - Diagnosis of obesity Exclusion Criteria: - Current or prior diagnosis of atrial fibrillation, atrial flutter or atrial tachycardia - Receiving chronic anticoagulation therapy - Hospice care - End stage renal disease - Diagnosis of moderate or greater dementia - Implantable pacemaker and/or defibrillator - History of skin allergies to adhesive patches